Publications
- Bleeding pattern and consumption of factor VIII concentrate in adult patients with haemophilia A without inhibitors in the Czech Republic between 2013 and 2021 (Czech National Haemophilia Programme registry data)2023 | Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Dilemmas on emicizumab in children with haemophilia A: A survey of strategies from PedNet centres2023 | Second Faculty of Medicine
- Consensual guidelines of the Czech National Haemophilia Programme (CNHP) for the diagnosis and treatment of patients with haemophilia, 3rd edition, year 20212021 | Second Faculty of Medicine, Faculty of Medicine in Pilsen
- Consensual guidelines of the Czech National Haemophilia Programme (CNHP) for the diagnosis and treatment of patients with congenital haemophilia and FVIII/ FIX inhibitors2021 | Second Faculty of Medicine, Faculty of Medicine in Pilsen
- Consensual guidelines of the Czech National Haemophilia Programme (CNHP) for replacement treatment of patients with haemophilia during invasive procedures and surgery, 2nd edition, year 20202020 | Second Faculty of Medicine, Faculty of Medicine in Pilsen
- Emicizumab - new treatment approach to haemophilia A2019 | Second Faculty of Medicine
- Emicizumab - a new direction of treatment in patients with haemophilia and inhibitor2019 | Second Faculty of Medicine
- Quality of life of pediatric patients with haemophilia in the Czech Republic - experiences of one centre2017 | Second Faculty of Medicine
- FVIII inhibitor development according to concentrate: Data from the EUHASS registry excluding overlap with other studies2016 | Second Faculty of Medicine
- Use of recombinant factor VIII Advate in paediatric patients First steps in the Czech Republic2009 | Second Faculty of Medicine
Loading network view...